Plasma inflammatory biomarkers predict CD4+ T-cell recovery and viral rebound in HIV-1 infected Africans on suppressive antiretroviral therapy.
Journal article
Kroeze S. et al, (2020), The Journal of infectious diseases
Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey
Journal article
Hemelaar J. et al, (2020), The Lancet HIV, 7, e772 - e781
Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward.
Journal article
Donovan J. et al, (2020), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71, 2002 - 2005
High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study)
Journal article
Marais S. et al, (2020), Wellcome Open Research, 4, 190 - 190
The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa
Journal article
Inzaule SC. et al, (2020), AIDS (London, England), 34, 1559 - 1566
ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network): a pilot protocol for case based antimicrobial resistance surveillance
Journal article
Turner P. et al, (2020), Wellcome Open Research, 5, 13 - 13
Is increasing pretreatment HIV drug resistance a real menace or minor detail?
Journal article
Inzaule SC. et al, (2020), The lancet. HIV, 7, e316 - e317
Low-Abundance Drug-Resistant HIV-1 Variants in Antiretroviral Drug-Naive Individuals: A Systematic Review of Detection Methods, Prevalence, and Clinical Impact.
Journal article
Mbunkah HA. et al, (2020), The Journal of infectious diseases, 221, 1584 - 1597
ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network): a pilot protocol for case based antimicrobial resistance surveillance
Journal article
Turner P. et al, (2020), Wellcome Open Research, 5, 13 - 13
ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network): a pilot protocol for case based antimicrobial resistance surveillance.
Journal article
Turner P. et al, (2020), Wellcome open research, 5
Management of intracranial tuberculous mass lesions: How long should we treat for?
Journal article
Marais S. et al, (2020), Wellcome Open Research, 4
The impact of HIV-1 subtypes on virologic and immunologic treatment outcomes at the Lagos University Teaching Hospital: A longitudinal evaluation.
Journal article
Ogbenna AA. et al, (2020), PloS one, 15
Standardized approaches for clinical sampling and endpoint ascertainment in tuberculous meningitis studies
Journal article
Rohlwink UK. et al, (2019), Wellcome Open Research, 4, 204 - 204
Distinct rates and patterns of spread of the major HIV-1 subtypes in Central and East Africa
Journal article
Faria NR. et al, (2019), PLOS Pathogens, 15, e1007976 - e1007976
High dose oral rifampicin to improve survival from adult tuberculous meningitis: A randomised placebo-controlled double-blinded phase III trial (the HARVEST study)
Journal article
Marais S. et al, (2019), Wellcome Open Research, 4, 190 - 190
Knowledge gaps and research priorities in tuberculous meningitis
Journal article
Seddon J. et al, (2019)
Tuberculous meningitis: new tools and new approaches required
Journal article
Seddon J. et al, (2019)
Checklists to guide the supportive and critical care of tuberculous meningitis
Journal article
Donovan J. et al, (2019)
Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
Journal article
Kroeze S. et al, (2019), The Journal of infectious diseases, 220, 1029 - 1033
Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens.
Journal article
Inzaule SC. et al, (2019), The Lancet. Infectious Diseases, 19, e246 - e252